Datamonitor, Dec 2007, Pages: 142
... 98 Other immunomodulators 99 Therapeutic vaccines have been difficult to develop 99 Clinical trial design in HCV is becoming increasingly complex 101 Patient ...
La Merie, Aug 2008, Pages: 90
... Cancer Therapy Cancer Vaccines May Fulfill an Unmet Need Preventive Cancer Vaccine Launches No Immediate Launch for Therapeutic Vaccines Emerging Approaches to ...
Datamonitor, March 2007, Pages: 250
... TLR-adjuvanted vaccines are compiled sorted by TLR receptor subtype and by therapeutic area as prophylactic and therapeutic vaccines. ...
Espicom Business Intelligence Ltd, Sep 2007, Pages: 184
... TLR-adjuvanted vaccines are compiled sorted by TLR receptor subtype and by therapeutic area as prophylactic and therapeutic vaccines. ...
Frost & Sullivan, March 2009, Pages: 36
... Cancer vaccine research is coming to fruition, with a number of products now in Phase III trials and 15 therapeutic cancer vaccines realistically expected to ...
Datamonitor, Dec 2006, Pages: 234
... Cancer vaccine research is coming to fruition, with a number of products now in Phase III trials and 15 therapeutic cancer vaccines realistically expected to ...
Frost & Sullivan, Dec 2008, Pages: 37
... and lower resistance. Besides therapeutics, vaccines are also considered a potential market for expansion. The number of patients ...
RNCOS E-Services Private Limited, Nov 2007, Pages: 135
Unmet needs across the cancer market remain high, with most therapies conferring low levels of specificity and high toxicity. Therapeutic cancer vaccines offe. ...
Jain PharmaBiotech, Nov 2009, Pages: 451
... to competitive pricing of therapeutic drugs, while in China, the presence of domestic companies seems to be concentrated in the vaccines market." Technologies ...
Datamonitor, Sep 2008, Pages: 147
... report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutic. ...
Bioseeker, Feb 2005, Pages: 175
838368, Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer, Targeted cancer therapies have achieved phenomenal growth, and many MAb ...
John Wiley and Sons Ltd, July 2009, Pages: 408
... antigen-sparing formulations. This makes them an attractive option for prophylactic and therapeutic vaccines. Scope - In-depth analysis ...
Datamonitor, May 2002 ... It is broadly admitted that therapeutic vaccines will initially and in the near future be efficient only on a limited tumor burden. ...
Landes Bioscience ... 8. Immunomodulation of existing responses: adjuvants for therapeutic vaccines. 9. Take another route. 9.1. Adjuvants for mucosal immunization. 9.2. ...
Bioseeker, July 2005, Pages: 204
... on Epidemiology Summary THERAPY & PROPHYLAXIS OF OPPORTUNISTIC INFECTIONS HIV Treatment HIV Therapeutic Vaccines <BR ...
La Merie, Aug 2009, Pages: 67
... Treatment of West Nile neuroinvasive disease Vaccines against WNV ... virus epidemics Coronavirus/severe acute respiratory syndrome Therapeutic approaches to SARS ...
